CV6 Therapeutics

Management

The CV6 Therapeutics leadership team combines deep scientific expertise with proven business acumen, leveraging decades of experience in drug development, translational research, and strategic execution to drive breakthrough therapies into real-world clinical impact.

Peter M. Wilson, PhD
Director of Science & Drug Development

Tess Barker, PhD
Project Manager (Consulting)

Glen Clack, MD
Chief Medical Officer (Consulting)

Richard Milliken, CA
Chair of the Board of Directors & CFO

Robert D. Ladner, PhD
Chief Executive Officer & Founder

Karl A. Mulligan, PhD
COO & Co-Founder CV6 (NI) Ltd.

CV6 Therapeutics is a drug development company focused on the discovery, development and commercialization of novel combination therapies